These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer. Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675 [TBL] [Abstract][Full Text] [Related]
12. Current status of gene therapy for lung cancer and head and neck cancer. Moon C; Oh Y; Roth JA Clin Cancer Res; 2003 Nov; 9(14):5055-67. PubMed ID: 14613982 [TBL] [Abstract][Full Text] [Related]
13. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation]. Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658 [TBL] [Abstract][Full Text] [Related]
14. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
15. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy. Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534 [TBL] [Abstract][Full Text] [Related]
16. Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects. Yi BR; O SN; Kang NH; Hwang KA; Kim SU; Jeung EB; Kim YB; Heo GJ; Choi KC Int J Oncol; 2011 Oct; 39(4):833-9. PubMed ID: 21769425 [TBL] [Abstract][Full Text] [Related]
17. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter]. Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of p53 in non-small-cell lung cancer. Komiya T; Hirashima T; Kawase I Oncol Rep; 1999; 6(1):19-28. PubMed ID: 9864395 [TBL] [Abstract][Full Text] [Related]
19. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Saeki T; Mhashilkar A; Chada S; Branch C; Roth JA; Ramesh R Gene Ther; 2000 Dec; 7(23):2051-7. PubMed ID: 11175318 [TBL] [Abstract][Full Text] [Related]
20. Viral and non-viral vectors for cancer gene therapy. Cristiano RJ Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]